Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$243.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Mar 17 | TARS | Tarsus Pharmaceuticals,… | SSELL | 375 | $69.42 | $26K | -1.5% | Open the original filing on SEC.gov |
| Mar 15 | TARS | Tarsus Pharmaceuticals,… | MEXER◆ | 2,511 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | TARS | Tarsus Pharmaceuticals,… | MEXER | 2,511 | — | — | +11.4% | Open the original filing on SEC.gov |
| Mar 5 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 17,161 | — | — | — | Open the original filing on SEC.gov |
| Mar 5 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 27,310 | — | — | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL | 2,078 | $79.50 | $165.2K | -8.6% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | MEXER◆ | 6,819 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | MEXER | 6,819 | — | — | +39.6% | Open the original filing on SEC.gov |